BTAI: Bullish Positive News // Decreasing vol w/ increasing price // Currently trading outside of fork // Target 88-103 in 8-12 weeks
Key stats
Market capitalization
517.24MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.92USD
About BioXcel Therapeutics, Inc
ISIN
US09075P1057
Sector
Health Technology
Industry
Biotechnology
Website
bioxceltherapeutics.com
CEO
Vimal D. Mehta
Headquarters
New Haven
Employees
183
Founded
2017
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in developing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. It also focuses on utilizing cutting-edge technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0